Application of recombinant adenovirus for in vivo gene delivery to spinal cord

Brain Research

Volumn 768, Issue 1-2, 1997, Pages 19-29

  Liu, Yi ^a   Himes, B Timothy ^a,b   Moul, Jon ^a   Huang, Wenlin ^a   Chow, Stella Y ^a   Tessler, Alan ^a,b   Fischer, Itzhak ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Galactosidase; Adenovirus; Clarke's nucleus; Cyclosporin A; Gene transfer; Immune response; Red nucleus; Spinal cord

Indexed keywords

BETA GALACTOSIDASE; CYCLOSPORIN A; NEUROTROPHIN;

ADENOVIRUS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; IMMUNITY; IMMUNOCYTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; NERVE FIBER REGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; RED NUCLEUS; SPINAL CORD; SPINAL CORD INJURY; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTIBODY FORMATION; BETA-GALACTOSIDASE; CYCLOSPORINE; FEMALE; GENE TRANSFER TECHNIQUES; GENES, REPORTER; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SPINAL; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINATION, GENETIC; SPINAL CORD INJURIES; TRANSGENES;

EID: 0030862006     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00587-8     Document Type: Article

References (44)

1. Akli S., Caillaud C., Vigne E., Stratford-Perricaudet L.D., Poenaru L., Perricaudet M., Kahn A., Peschanski M.R. Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet. 3:1993;224-228.
2. Bajocchi G., Feldman S.H., Crystal R.G., Mastrangeli A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet. 3:1993;229-234.
3. Bernstein-Goral H., Bregman B.S. Spinal cord transplants support the regeneration of axotomized neurons after spinal cord lesions at birth: a quantitative double-labeling study. Exp. Neurol. 123:1993;118-132.
4. Bregman B.S., Kunkel-Bagden E., Reier P.J., Dai H.N., McAtee M., Gao D. Recovery of function after spinal cord injury: mechanisms underlying transplant-mediated recovery of function differ after spinal cord injury in newborn and adult rats. Exp. Neurol. 123:1993;3-16.
5. Brundin P., Widner H., Nilsson O.G., Strecker R.E., Bjorklund A. Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier. Exp. Brain Res. 75:1989;195-207.
6. Byrnes A.P., MacLaren R.E., Charlton H.M. Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J. Neurosci. 16:1996;3045-3055.
7. Byrnes A.P., Rusby J.E., Wood M.J., Charlton H.M. Adenovirus gene transfer causes inflammation in the brain. Neuroscience. 66:1995;1015-1024.
8. Crandall J.E., Tobet S.A., Fischer I., Fox T.O. Age-dependent expression of microtubule-associated protein 2 in the ventromedial nucleus of the hypothalamus. Brain Res. Bull. 22:1989;571-574.
9. Crystal R.G. Transfer of genes to humans: early lessons and obstacles to success. [Review]. Science. 270:1995;404-410.
10. Dannenberg A.M. Jr., Suga M., Garcia-Gonzales J.E. Macrophages in granulomas: histochemical evidence suggesting local control of heterogeneous functions. Hamatologie und Bluttransfusion. 27:1981;109-119.
11. Davidson B.L., Allen E.D., Kozarsky K.F., Wilson J.M., Roessler B.J. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 3:1993;219-223.
12. Davidson B.L., Doran S.E., Shewach D.S., Latta J.M., Hartman J.W., Roessler B.J. Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer. Exp. Neurol. 125:1994;258-267.
13. Diener P.S., Bregman B.S. Neurotrophic factors prevent the death of CNS neurons after spinal cord lesions in newborn rats. Neuroreport. 5:1994;1913-1917.
14. Doran S.E., Ren X.D., Betz A.L., Pagel M.A., Neuwelt E.A., Roessler B.J., Davidson B.L. Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption. Neurosurgery. 36:1995;790-965.
15. Durham H.D., Lochmuller H., Jani A., Acsadi G., Massie B., Karpati G. Toxicity of replication-defective adenoviral recombinants in dissociated cultures of nervous tissue. Exp. Neurol. 140:1996;14-20.
16. Finiels F., Gimenez y Ribotta M., Barkats M., Samolyk M.L., Robert J.J., Privat A., Revah F., Mallet J. Specific and efficient gene transfer strategy offers new potentialities for the treatment of motor neurone diseases. NeuroReport. 7:1995;373-378.
17. Finsen B., Poulsen P.H., Zimmer J. Xenografting of fetal mouse hippocampal tissue to the brain of adult rats: effects of cyclosporin A treatment. Exp. Brain Res. 70:1988;117-133.
18. Ghadge G.D., Roos R.P., Kang U.J., Wollmann R., Fishman P.S., Kalynych A.M., Barr E., Leiden J.M. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther. 2:1995;132-137.
19. Giehl K., Mestres P., Tetzlaff W. BDNF and NT-3 exert different and overlapping effects on GAP-43 and T-alpha-1-tubulin expression in axotomized corticospinal neurons of the rat. Soc. Neurosci. Abstr. 21:1995;1056.
20. Himes B.T., Goldberger M.E., Tessler A. Grafts of fetal central nervous system tissue rescue axotomized Clarke's nucleus neurons in adult and neonatal operates. J. Comp. Neurol. 339:1994;117-131.
21. Himes B.T., Solowska-Baird J., Boyne L., Snyder E.Y., Tessler A., Fischer I. Grafting of genetically modified cells that produce neurotrophins in order to rescue axotomized neurons in rat spinal cord. Soc. Neurosci. Abstr. 21:1995;537.
22. Jaffe H.A., Danel C., Longenecker G., Metzger M., Setoguchi Y., Rosenfeld M.A., Gant T.W., Thorgeirsson S.S., Stratford-Perricaudet L.D., Perricaudet M. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1:1992;372-378.
23. Kobayashi N.R., Bedared A.M., Tetzlaff W. BDNF reverses the atrophy of chronically injured rat rubrospinal neurons after cervical (C3) axotomy. Soc. Neurosci. Abstr. 21:1995;1056.
24. Lal B., Cahan M.A., Couraud P.O., Goldstein G.W., Laterra J. Development of endogenous beta-galactosidase and autofluorescence in rat brain microvessels: implications for cell tracking and gene transfer studies. J. Histochem. Cytochem. 42:1994;953-956.
25. Le Gal La Salle G., Robert J.J., Berrard S., Ridoux V., Stratford-Perricaudet L.D., Perricaudet M., Mallet J. An adenovirus vector for gene transfer into neurons and glia in the brain. Science. 259:1993;988-990.
26. Lisovoski F., Cadusseau J., Akli S., Caillaud C., Vigne E., Poenaru L., Stratford-Perricaudet L., Pericaudet M., Kahn A., Peschanski M. In vivo transfer of a marker gene to study motoneuronal development. Neuroreport. 5:1994;1069-1072.
27. P.R. Lowenstein, G.W.G. Wilkinson, M.G. Castro, A.F. Shering, A.R. Fooks, D. Bain, Non-neurotropic adenovirus: a vector for gene transfer to the brain and possible gene therapy of neurological disorders, in: D. Latchman (Ed.), Genetic Manipulation of the Nervous System, Academic Press, New York, 1996, pp. 11-39.
28. Michelle M. Foreign protein not viral proteins seem responsible for immune response. Gene Ther. 19:1996;3-4.
29. Milligan C.E., Cunningham T.J., Levitt P. Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain. J. Comp. Neurol. 314:1991;125-135.
30. Neve R.L. Adenovirus vectors enter the brain. [Review]. Trends Neurosci. 16:1993;251-253.
31. Ooboshi H., Welsh M.J., Rios C.D., Davidson B.L., Heistad D.D. Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ. Res. 77:1995;7-13.
32. Ragot T., Vincent N., Chafey P., Vigne E., Gilgenkrantz H., Couton D., Cartaud J., Briand P., Kaplan J.C., Perricaudet M., Kahn A. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature. 361:1993;647-650.
33. Ridoux V., Robert J.J., Zhang X., Perricaudet M., Mallet J., Le Gal La Salle G. Adenoviral vectors as functional retrograde neuronal tracers. Brain Res. 648:1994;171-175.
34. Rosenfeld M.A., Siegfried W., Yoshimura K., Yoneyama K., Fukayama M., Stier L.E., Paakko P.K., Gilardi P., Stratford-Perricaudet L.D., Perricaudet M., Jallat S., Pavirani A., Lecocq J.-P., Crystal R.G. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science. 252:1991;431-434.
35. Sendtner M., Holtmann B., Kolbeck R., Thoenen H., Barde Y.A. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature. 360:1992;757-759.
36. Senut M.C., Tuszynski M.H., Raymon H.K., Liou N.H., Jones K.R., Reichardt L.F. Regional differences in responsiveness of adult CNS axons to grafts of cells expressing human neurotrophin 3. Exp. Neurol. 134:1995;36-55.
37. W. Tetzlaff, N.R. Kobayashi, K.M. Giehl, B.J. Tsui, S.L. Cassar, A.M. Bedard, Response of rubrospinal and corticospinal neurons to injury and neurotrophins, in: F.J. Sell (Ed.), Prog. Brain Res., Vol. 103, Elsevier, Amsterdam, 1994, pp. 271-286.
38. D.J. Tracey, Ascending and descending pathways in the spinal cord, in: G. Paxinos (Ed.), The Rat Nervous System, 2nd ed., Academic Press, New York, 1995, pp. 67-76.
39. Wang Q., Finer M.H. Second-generation adenovirus vectors. [Review]. Nature Med. 2:1996;714-716.
40. Wood M.J.A., Charlton H.M., Wood K.J., Kajiwara K., Byrnes A. Immune responses to adenovirus vectors in the nervous system. Trends Neurosci. 19:1996;497-501.
41. Yang Y., Li Q., Ertl H.C., Wilson J.M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:1995;2004-2015.
42. Yang Y., Nunes F.A., Berencsi K., Furth E.E., Gonczol E., Wilson J.M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA. 91:1994;4407-4411.
43. Yang Y., Wilson J.M. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J. Immunol. 155:1995;2564-2570.
44. Yang Y., Xiang Z., Ertl H.C., Wilson J.M. Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;7257-7261.